Viewing Study NCT01980056


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-01-01 @ 4:37 AM
Study NCT ID: NCT01980056
Status: COMPLETED
Last Update Posted: 2019-02-19
First Post: 2013-11-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy
Sponsor: Weill Medical College of Cornell University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-10-25
Start Date Type: ACTUAL
Primary Completion Date: 2015-01-19
Primary Completion Date Type: ACTUAL
Completion Date: 2015-01-19
Completion Date Type: ACTUAL
First Submit Date: 2013-11-01
First Submit QC Date: None
Study First Post Date: 2013-11-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-11-01
Results First Submit QC Date: None
Results First Post Date: 2018-12-28
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-01-24
Last Update Post Date: 2019-02-19
Last Update Post Date Type: ACTUAL